From a $10 billion bioeconomy to over $190 billion, indigenous CAR-T therapy, and a booming startup ecosystem highlight 12 years of transformation in India’s science and technology landscape
Discussions focus on integrating ECG diagnostics into AI-enabled E-ICU Command Centre and expanding technology-driven healthcare access across underserved regions
MabionCD20 is a monoclonal antibody originally developed by Mabion as a biosimilar candidate to MabThera and Rituxan therapies
Exclusive partnership introduces globally benchmarked stem cell processing platform aimed at improving stem cell recovery, quality, and long-term therapeutic potential
Veteran quality professional with over 20 years of industry experience to lead quality operations at Unit-4 API manufacturing facility
New facility will open by October 2026 and house 500 process development specialists
Both nations deepen cooperation in health innovation, AI-driven healthcare, biomedical research, data sharing, and life sciences to accelerate next-generation healthcare solutions
New-generation cardiac ablation technology expands treatment options for atrial fibrillation patients, offering a non-thermal approach to improve safety and procedural efficiency
Patnaik stressed early diagnosis, rapid treatment, and aggressive surveillance as the backbone of elimination efforts
Award highlights Hyderabad-based innovation hub’s role in advancing healthcare technology, clinical intelligence, and global operational excellence
Subscribe To Our Newsletter & Stay Updated
